Compounding transparency
In February 2026 the FDA issued Belle Health a warning letter: product images on its site were labeled as if Belle were the compounding pharmacy when its medications are actually compounded by third-party pharmacies, which the FDA called misleading (the letter is public at fda.gov). OrderlyMeds states its sourcing plainly: medications compounded in state-licensed 503A pharmacies regulated by state boards of pharmacy. The full disclosure is at the bottom of this page.
